Smarter, safer, and more cost-effective treatment methods.

Aurealis Pharma, a privately-held biopharmaceutical company, has developed a broadly applicable technology platform that enables three-in-one combination therapy in one single product. This effective, safe and economical threatment method can greatly improve the quality of life of people suffering from these major unmet medical needs such as cancer.

  • 08.02.2019

    Aurealis Pharma Announces 7.8MCHF Financing to Advance the Chronic Wound Lead Candidate AUP-16 to Diabetic Foot Ulcer Patients under New Brand Aurealis Therapeutics AG

News archive »


Aurealis Pharma

Embracing science. Enhancing lives.

Site by Mainostoimisto Ad Kiivi